Next report date
Report period
Q1 2024
EPS estimate
−0.30USD
Revenue estimate
—
−0.84USD
−7.99 MUSD
6.00 MUSD
12.52 M
About Coya Therapeutics, Inc.
Sector
Industry
CEO
Howard H. Berman
Website
Headquarters
Houston
Employees (FY)
8
Founded
2020
FIGI
BBG00Z4HBCB9
Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of COYA is 8.60 USD — it has increased by 2.02% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Coya Therapeutics, Inc. stocks are traded under the ticker COYA.
Coya Therapeutics, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
COYA stock is 4.17% volatile and has beta coefficient of 1.11. Check out the list of the most volatile stocks — is Coya Therapeutics, Inc. there?
COYA earnings for the last quarter are −0.34 USD per share, whereas the estimation was −0.35 USD resulting in a 3.45% surprise. The estimated earnings for the next quarter are 0.26 USD per share. See more details about Coya Therapeutics, Inc. earnings.
Yes, you can track Coya Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
COYA stock has risen by 2.02% compared to the previous week, the month change is a 3.48% fall, over the last year Coya Therapeutics, Inc. has showed a 93.14% increase.
COYA net income for the last quarter is 1.27 M USD, while the quarter before that showed −3.42 M USD of net income which accounts for 137.00% change. Track more Coya Therapeutics, Inc. financial stats to get the full picture.
No, COYA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, COYA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Coya Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 8.00 employees. See our rating of the largest employees — is Coya Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Coya Therapeutics, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Coya Therapeutics, Inc. stock shows the neutral signal. See more of Coya Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Coya Therapeutics, Inc. future price: according to them, COYA price has a max estimate of 15.00 USD and a min estimate of 14.00 USD. Read a more detailed Coya Therapeutics, Inc. forecast: see what analysts think of Coya Therapeutics, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Coya Therapeutics, Inc. EBITDA is −7.33 M USD, and current EBITDA margin is −122.17%. See more stats in Coya Therapeutics, Inc. financial statements.